source
- Revolution Medicines' pancreatic cancer therapy Rasonque moves closer to European approval after FDA clearanceRevolution Medicines' experimental drug Rasonque, aimed at treating pancreatic cancer, has received a recommendation for approval from European regulators. The recommendation follows an earlier po…
- Hospitals Turn to Longevity Clinics as New Revenue StreamSTAT's biotech podcast "The Readout LOUD" featured a discussion about the rapid growth of longevity clinics that are being opened by hospitals. Reporters noted that the longevity medicine market i…